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ax, a member of the Bcl-2 family, translocates to mi-
tochondria during apoptosis, where it forms oligo-
mers which are thought to release apoptogenic fac-
tors such as cytochrome 
 
c
 
. Using anoikis as a model
system, we have examined spatial and temporal changes in
Bax distribution. Bax translocates to mitochondria within
15 min of detaching cells from extracellular matrix, but mi-
tochondrial permeabilization does not occur for a number
of hours. The formation of Bax oligomers and perimito-
chondrial clusters occurs concomitant with caspase activa-
B
 
tion and loss of mitochondrial membrane potential, before
nuclear condensation. Cells can be rescued from apoptosis
if they are replated onto extracellular matrix within an
hour, whereas cells detached for longer could not. The loss
of ability to rescue cells from anoikis occurs after Bax
translocation, but before the formation of clusters and cyto-
chrome 
 
c
 
 release. Our data suggest that Bax regulation oc-
curs at several levels, with formation of clusters a late
event, and with critical changes determining cell fate oc-
curring earlier.
 
Introduction
 
Apoptosis is a mechanism for removing unwanted or dam-
aged cells. Its endpoint is the activation of a family of pro-
teases (the caspases) which are responsible for the morpho-
logical hallmarks of cell death (Green, 2000). However, the
initial decision to embark on the apoptotic pathway occurs
considerably earlier, and before a cell can be distinguished
from a neighbor that will not die. Diverse insults can set a
cell on this pathway. Cytotoxic drugs, UV irradiation, and
exposure to ligands for transmembrane death receptors (such
as FAS or TNF-R) are essentially positive apoptotic signals
from which cells cannot be rescued. Conversely, cells also re-
quire the presence of survival signals to suppress apoptosis,
such as growth factors or adhesion to ECM (Gilmore et al.,
2000). Removal of survival factors leads to apoptosis, but
unlike cytotoxic signals, cells are not irreversibly committed,
and can be rescued if signaling is restored in time. This pro-
vides an opportunity to examine the molecular events associ-
ated with commitment.
Proapoptotic Bax and Bak are essential regulators of the
mitochondrial pathway of apoptosis (Lindsten et al., 2000;
Ranger et al., 2001; Wei et al., 2001). Bak resides perma-
nently on the outer mitochondrial membrane (OMM),
whereas Bax is normally found in the cytosol of healthy cells
and translocates to the OMM during apoptosis (Hsu et al.,
1997; Wolter et al., 1997; Goping et al., 1998; Gross et al.,
1998). Both undergo a conformational change, which may
be an obligatory step in their proapoptotic function (De-
sagher et al., 1999; Griffiths et al., 1999; Nechushtan et al.,
1999). In the case of Bax, transition to this alternative con-
formation correlates with translocation to mitochondria.
Bax and/or Bak are required for mitochondrial mem-
brane permeabilization (MMP; Wei et al., 2001). How
MMP occurs is controversial, and a number of possible
models have been proposed (Martinou and Green, 2001;
Zamzami and Kroemer, 2001). During apoptosis, mito-
chondrial Bax forms large complexes, whereas cytosolic Bax
is a monomeric 21-kD protein (Antonsson et al., 2000,
2001; Eskes et al., 2000; Nechushtan et al., 2001). The role
of these complexes is unclear, but current models suggest
that they regulate mitochondrial morphology and perme-
ability via existing OMM proteins, or by forming de novo
channels (Jurgensmeier et al., 1998; Narita et al., 1998;
Martinou and Green, 2001; Zamzami and Kroemer, 2001).
Ultimately, they cause mitochondria to release a host of fac-
tors from the intermembrane space, including cytochrome
 
c
 
, SMAC/Diablo, and apoptosis-inducing factor, leading to
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Figure 1. Bax translocates to mitochondria and forms high mol wt oligomers during anoikis. (a) FSK-7 cells, adherent or detached (maintained 
on poly-HEMA for 15 min or 4 h), were separated into soluble (S) and membrane (M) fractions before SDS-PAGE and immunoblotting with 
polyclonal anti-Bax (top). 4 mM CHAPS was added, and Bax was immunoprecipitated with anti-Bax 62M. Immunoprecipitates were separated 
by SDS-PAGE and were immunoblotted with anti-Bax 5B7 (bottom). (b) Cells expressing the OMM marker YFP-XT were detached for various 
times before cytospinning, and were immunostained with the activation-dependent antibody 62M. 62M reactivity is seen at discrete regions 
on mitochondria at all time points. Bar, 5  m. (c) Soluble and membrane fractions from adherent cells or cells maintained on poly-HEMA for 
4 h were isolated as above. CHAPS was added to a final concentration of 4 mM, and the fractions were concentrated. 5 mg protein from each 
fraction was loaded onto a Sephacryl S100-HR column (see Materials and methods). Separated fractions were analyzed by SDS-PAGE and 
immunoblotting for Bax. (d) Membrane fractions from FSK-7 cells detached for 4 h were separated by size-exclusion chromatography as 
above. Fractions containing high (oligo) and low (mono) mol wt Bax complexes were collected. Fractions were concentrated and separated 
into three equal parts. These were treated with BS3 (with or without addition of 0.1% Triton X-100). Samples were separated by SDS-PAGE 
and were immunoblotted for Bax. Cytosolic Bax from adherent cells (Adh) was run for comparison after identical treatment. (e) Membrane 
fractions isolated from adherent cells or cells detached for various times and separated by size-exclusion chromatography were analyzed by 
SDS-PAGE and immunoblotting for Bax. Total soluble (S) and membrane (M) fractions show Bax translocation at each time point. (f) Membrane 
fractions prepared from adherent cells or cells detached for 15 min, 1 h, or 4 h were spilt into three and treated with 5 mM BS3 in the presence 
or absence of 0.1% Triton-X100. Samples were analyzed by SDS-PAGE and were immunoblotted for Bax.T
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cell death (Degterev et al., 2001; Waterhouse et al., 2002).
Mitochondrial fission also occurs at this time, in which Bax
has also been implicated (Frank et al., 2001; Karbowski et
al., 2002).
Inhibition of adhesion in epithelial cells leads to apoptosis
(anoikis; Frisch and Ruoslahti, 1997; Gilmore et al., 2000).
Bax translocates to mitochondria within 15 min of removal
of cells from ECM, but they do not die immediately, and it
is a number of hours before MMP occurs. Furthermore, if
cells are replated, Bax exits the mitochondria and cells sur-
vive, suggesting that Bax translocation does not, per se, com-
mit cells to apoptosis (Gilmore et al., 2000). Here, we ex-
amine spatial and temporal changes in Bax localization,
conformation, and oligomerization during anoikis. Bax ini-
tially translocates to mitochondria as an inactive monomer.
A fraction of this Bax undergoes a conformational change af-
ter translocation, but this precedes MMP and apoptosis by
several hours. The formation of prominent Bax clusters is a
late event coinciding with activation of all mitochondrial
Bax, MMP, and apoptosis. We have also investigated the
time window during which epithelial cells can be rescued
from anoikis. We find that the point beyond which cells are
committed is before Bax forms large perimitochondrial clus-
ters and cytochrome 
 
c
 
 is released. These results suggest that
critical events committing a cell to die occur before the de-
tectable changes in mitochondrial permeability.
 
Results
 
Bax translocates to mitochondria 
as an inactive monomer
 
Adhesion-dependent mammary epithelial cells undergo anoi-
kis after detachment from ECM (Gilmore et al., 2000). Bax
translocates to mitochondria within 15 min of detachment,
but apoptosis is a slower stochastic event, occurring after
several hours. We wanted to determine if this delay between
apoptotic signal and death was related to changes in the con-
formation and organization of Bax.
First, we asked if the conformational change occurs be-
fore or subsequent to Bax translocation. FSK-7 mammary
epithelial cells were maintained as an adherent monolayer
or detached and cultured on a nonadhesive substrate (poly-
HEMA) for 15 min or 4 h. Cytosol and membrane frac-
tions were prepared and assayed for the presence of Bax
(Fig. 1 a, top). In adherent cells, Bax is predominantly cyto-
solic. Detaching cells for 15 min results in a significant
amount of Bax translocating to the membrane fraction,
which persists after longer times in suspension. To deter-
mine the conformational state of Bax, we immunoprecipi-
tated from these fractions (in the presence of 0.25%
CHAPS) using anti-Bax pAb 62M, which recognizes a BH3
domain–proximal epitope. This antibody only recognizes
the proapoptotic conformation of Bax (Pullan et al., 1996;
Gilmore et al., 2000). Only Bax from the membrane frac-
tion of detached cells was precipitated by 62M (Fig. 1 a,
bottom). 62M-reactive Bax was detected in the membrane
fraction of cells detached from ECM for 15 min. No Bax
was immunoprecipitated from the cytosolic fraction of de-
tached cells, or from the cytosolic and membrane fractions
of adherent cells. This change in reactivity with 62M was
not due to covalent modification, as addition of Triton
X-100 allowed Bax to be immunoprecipitated from all frac-
tions (unpublished data). These data demonstrate that
the Bax molecules that have undergone a conformational
change can only be found in the membrane fraction of cells
undergoing anoikis.
To determine the subcellular location of activated Bax
during anoikis, cells maintained in suspension for various
times were cytospun and immunostained with anti-Bax
62M (Fig. 1 b). Previously, we have shown that this anti-
body does not immunostain adherent FSK-7 cells, but does
stain detached cells (Gilmore et al., 2000; Wang et al.,
2003). Mitochondria were visualized by transfecting cells
with a YFP-tagged marker for the OMM (YFP-XT). At all
times after detachment, active Bax was observed in punctate
clusters associated with mitochondria. These perimitochon-
drial clusters appeared identical to those described for GFP-
Bax after staurosporine treatment (Nechushtan et al., 2001).
Staurosporine treatment of HeLa cells results in mito-
chondrial Bax forming high mol wt complexes (Antonsson
et al., 2001). Perimitochondrial clusters seen with GFP-Bax
(Nechushtan et al., 2001) and here with anti-Bax 62M may
represent these complexes. As we observed 62M-reactive Bax
only in perimitochondrial clusters, we asked if, during
anoikis, membrane-associated Bax was exclusively in large
complexes, or whether it initially translocated as a mono-
mer. Cytosolic and membrane fractions were prepared in
CHAPS and separated by size-exclusion chromatography. In
adherent cells, Bax is cytosolic, and elutes as a single peak
consistent with it being a monomer (Fig. 1 c). Cytosolic Bax
from cells on poly-HEMA for 4 h is also a single species
of monomer, suggesting that, as with the conformational
change, oligomerization does not precede translocation.
Membrane-associated Bax in detached cells elutes as two
peaks, both low and high mol wts. The latter elutes 
 
 
 
200
kD in size, consistent with previous data (Antonsson et al.,
2001).
Next, these isolated S100 chromatography fractions were
cross-linked using the homo-bifunctional reagent BS3. By
SDS-PAGE, Bax from adherent cells runs as a single band
(Fig. 1 d, band 1). Bax in both the high and low mol wt
S100 fractions of detached cells also run as a single bands
under denaturing conditions (Fig. 1 d, band 1). On cross-
linking, cytosolic Bax is still a discrete band by SDS-PAGE,
but migrates slightly faster (Fig. 1 d, band 2), suggesting in-
ternal cross-links, consistent with its folded structure (Su-
zuki et al., 2000). Addition of Triton X-100 before cross-
linking produces a band indicative of Bax homodimers (Fig.
1 d, band 3), also consistent with previous data (Hsu and
Youle, 1998). The low mol wt fraction from membranes iso-
lated from detached cells behaves identically to cytosolic Bax
when cross-linked with BS3. However, the high mol wt frac-
tion does not show any immunoreactive bands after cross-
linking, although some immunoreactive material was seen in
the stacking gel (unpublished data). Identical results were
seen with a number of anti-Bax antibodies (unpublished
data). Furthermore, this fraction was insensitive to the addi-
tion of Triton X-100, and no dimer-sized band was induced.T
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These data show that monomeric and oligomeric forms of
Bax are both associated with the membrane fraction of de-
tached cells.
We examined the kinetics of complex formation during
anoikis. Membrane fractions isolated from adherent cells or
cells on poly-HEMA for various times were extracted in
CHAPS and separated by S100 chromatography. Very little
Bax is seen in the membrane fraction of adherent cells (Fig. 1
e). After detachment for 15 min, the majority of Bax in the
membrane fraction is in the low mol wt, monomeric form.
With detachment for longer periods, increasing amounts of
Bax are found in the high mol wt complex. Membrane frac-
tions isolated from detached cells were also cross-linked with
BS3. Consistent with the gel filtration data, significant
amounts of Bax on the membrane after detachment for 15
min is a monomer (Fig. 1 f). In the 15-min sample, Bax was
cross-linked into a discrete, faster migrating band (Fig. 1 f,
band 2). Triton X-100 produced a cross-linked dimer-sized
band (Fig. 1 f, band 3), identical to cytosolic Bax from adher-
ent cells (Fig. 1 d). Bax from cells on poly-HEMA for 1 h was
also largely monomeric. However, membrane fractions from
cells detached for 4 h showed a significant decrease in the
amount of monomeric Bax, as judged by absence of the faster
migrating cross-linked band (Fig. 1 f, band 2) and the Triton
X-100–induced dimer (Fig. 1 f, band 3).
If cross-linking with BS3 resulted in no 62M immunore-
active bands by Western blotting, why were 62M-positive
clusters seen associated with mitochondria by immunofluo-
rescence? It was estimated that GFP-Bax clusters contain
thousands of molecules, suggesting a mol wt much greater
than 200 kD (Nechushtan et al., 2001). Complexes of this
size may be largely insoluble with extraction conditions re-
quired to isolate native Bax. To examine this, we separated
cells into cytosolic and membrane fractions as before. The
membrane fraction was extracted with 0.25% CHAPS, and
the CHAPS-insoluble material was solubilized in SDS-
PAGE sample buffer. We compared all three fractions by
immunoblotting for Bax (Fig. 2 a). In adherent cells, the
majority of Bax was found in the cytosolic fraction. All de-
tached cell samples had a proportion of Bax present in the
CHAPS-insoluble membrane fraction. However, in cells
detached for 4 h, the majority of Bax was associated with
the CHAPS-insoluble fraction. The amount of Bax ex-
tracted was not increased with higher concentrations of
CHAPS (unpublished data). Next, we asked if perimito-
chondrial Bax clusters represented this CHAPS-insoluble
material. Cells expressing YFP-Bax were maintained on
poly-HEMA for 5 h, and then either fixed in 4% formalde-
hyde or extracted with 0.25% CHAPS before fixation.
They were immunostained for cytochrome 
 
c
 
 and the mito-
chondrial membrane protein TOM-20 (Fig. 2 b). TOM-20
was not extracted by CHAPS, whereas cytochrome 
 
c
 
 stain-
ing was diminished. However, cells expressing YFP-Bax
showed identical perimitochondrial clusters with or without
CHAPS extraction. Adherent cells extracted with CHAPS
did not have any detectable cytosolic YFP-Bax (unpub-
lished data).
These experiments demonstrate that Bax is a cytosolic
monomer in adherent epithelial cells, and that during anoikis,
it redistributes within 15 min to the OMM as a monomer.
The conformational change associated with Bax activation is
only found with protein associated with the membrane frac-
tion. Subsequent to translocation, Bax forms oligomeric com-
plexes. Over time, Bax progressively associates into larger and
more insoluble complexes, ultimately resulting in the large
clusters described here and elsewhere (Nechushtan et al.,
2001). These complexes are largely insoluble in the condi-
tions required to isolate native Bax, suggesting that the 200-
kD complexes isolated in a number of reports (Eskes et al.,
2000; Antonsson et al., 2001) represent only a fraction of the
oligomeric Bax on apoptotic mitochondria.
 
Spatial and temporal relationship between Bax 
activation complex formation and apoptosis
 
The experiments just mentioned raised a number of questions
regarding the spatial and temporal relationship between Bax
translocation, the formation of large complexes, and MMP.
Furthermore, the requirement of any of these events for
anoikis was unclear. To address this, we isolated primary epi-
thelial cells from mid-pregnant Bax-null mice and wild-type
Figure 2. During anoikis, the majority of Bax becomes resistant 
to CHAPS extraction. (a) FSK-7 cells, either adherent or detached 
for various times, were separated into soluble (Sol) and membrane 
fractions. The membrane fraction was extracted in 0.25% CHAPS 
and the insoluble material was removed by centrifugation. The pellet 
was solubilized in SDS-PAGE sample buffer (Insol). Samples were 
separated by SDS-PAGE and immunoblotted for Bax. (b) Cells 
expressing YFP-Bax were detached for 5 h before cytospinning, and 
either fixed in 4% formaldehyde or extracted at RT in PBS/0.25% 
CHAPS for 2 min and then fixed. Cells were immunostained for 
cytochrome c and TOM-20. Note that cells with clusters of YFP-Bax 
do not show mitochondrial cytochrome c. The nontransfected cell 
fixed before permeabilization still has mitochondrial cytochrome c.T
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counterparts. These were detached from ECM for 5 h, and
apoptosis was quantified (Fig. 3 a). Bax 
 
 
 
/
 
 
 
 cells showed a
marked delay in the onset of apoptosis, as well as having a
lower baseline level of cell death in monolayer culture.
It was unclear if the punctate Bax clusters seen by 62M im-
munostaining represented all the Bax present on the mito-
chondrial surface, or whether only a fraction of the protein on
the OMM was in the active conformation. One difficulty in
addressing this is the scarcity of antibodies that recognize the
inactive conformation of Bax. To address this, we used expres-
sion of YFP-Bax. This has inherent problems, as overexpres-
sion of YFP-Bax alone can induce apoptosis in the absence of
an apoptotic stimulus (Wolter et al., 1997). First, we deter-
mined what amount of YFP-Bax we could transfect FSK-7
cells with in order to visualize Bax without inducing signifi-
cant apoptosis and cluster formation in the absence of detach-
ment. FSK-7 cells were transfected with increasing amounts
of pEYFP-Bax and grown for 24 h. Both the adherent and
floating cells were collected and the number of transfected
cells showing apoptotic nuclear morphology were quantified
(Fig. 3 b). Cells that were apoptotic invariably showed punc-
tate YFP-Bax clusters. Cells transfected with the Bax BH3 do-
main alone fused to YFP showed almost 100% apoptosis,
whereas 
 
 
 
5% of cells expressing YFP-Bax with an inactivat-
ing mutation in the BH3 domain were dead. Most cells ex-
pressing wild-type YFP-Bax were not apoptotic, though
increasing amounts of YFP-Bax increased this proportion.
However, the majority of apoptotic cells were found in the su-
pernatant, and were easily removed. Consequently, most
transfected cells used in subsequent experiments were not ap-
optotic and contained cytosolic YFP-Bax before detachment.
Figure 3. Bax is required for anoikis, and expressed YFP-Bax does 
not induce significant apoptosis before detachment. (a) Primary 
mammary epithelial cells from wild-type (WT) and Bax-null ( / ) 
mice were maintained in suspension for 5 h. Apoptosis was 
assessed by nuclear morphology. (b) Cells transfected with varying 
amounts of YFP-Bax or 0.5  g YFP-BH3 (BH3) or YFP-Bax with an 
inactive BH3 domain (Mut) were stained with Hoescht 18 h after 
transfection. YFP-positive cells were assayed for apoptosis by 
nuclear morphology. Error bars are SEM from three experiments.
Figure 4. Spatial and temporal relationship 
between Bax activation and formation of mito-
chondrial-associated clusters. FSK-7 cells trans-
fected with YFP-Bax were fixed while adherent, 
or were detached for various times before cyto-
spinning. (a) Cell expressing YFP-Bax and HcRed-
XT. Bax colocalizes with mitochondria 15 min and 
1 h after detachment, but after 5 h, YFP-Bax is 
restricted to discrete clusters. Bar, 15  m. (b) YFP-
Bax–expressing cells were detached for 15 min, 
1 h, and 5 h. After fixation, cells were immuno-
stained with anti-Bax 62M and anti-mtHsp70. 
At 15 min and 1 h, YFP-Bax colocalizes extensively 
with mtHsp70, but 62M reactivity is more restricted. 
At 5 h, YFP-Bax does not colocalize with mtHsp70, 
but is now completely coincident with 62M stain-
ing. Note that the cell at 5 h has a condensed and 
fragmented nucleus. All cells with this distribution 
of Bax and 62M reactivity had similar nuclei. 
Bottom shows boxed areas in greater detail. Bar, 
15  m. (c) Loss of cytochrome c occurs along with 
Bax redistribution into clusters. Cells expressing 
YFP-Bax were cytospun at various times after 
detachment and immunostained with monoclonal 
anti-cytochrome c and anti-Bax 62M. Cytochrome c 
is not seen in mitochondria of cells that have com-
plete coincidence of 62M reactivity and YFP-Bax. 
Cells that have discrete foci of 62M reactivity but extensive YFP-Bax on mitochondria also have mitochondrial cytochrome c. No exceptions 
to this were observed. Bottom shows boxed areas in detail.T
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To assess the spatial and temporal events after Bax translo-
cation, cells were cotransfected with YFP-Bax and a fluores-
cent marker for the OMM (HcRed-XT). In adherent cells,
YFP-Bax showed a diffuse, cytosolic distribution (Fig. 4 a).
However, 15 min after detachment, YFP-Bax was localized
over the entire surface of the mitochondria, in contrast to
the distribution seen with anti-Bax 62M. This distribution
changed over time, and after 5 h in suspension, the majority
of cells showed YFP-Bax in perimitochondrial clusters. It was
striking that all cells that showed this perimitochondrial distri-
bution also had apoptotic nuclei, shown by Hoechst staining.
The Bax that we had previously localized with 62M (Fig. 1
b) was endogenous protein, whereas here, we saw expressed
YFP-Bax showing a different localization at early time points
after detachment (i.e., uniformly distributed over the mito-
chondrial surface). To determine if this was an overexpres-
sion artifact, cells expressing YFP-Bax were detached for vari-
ous times and the relative distributions of YFP-Bax and
62M-reactive Bax were examined. Cells were immunostained
with anti-Bax 62M and monoclonal anti-mtHsp-70 (Fig. 4
b). Although YFP-Bax was distributed over the entire mito-
chondrial surface at 15 min and 1 h (with extensive colocal-
ization between YFP-Bax and mtHsp70), 62M reactivity was
still only seen at discrete foci (Fig. 4 b, enlarged images). This
distribution did not change until cells developed apoptotic
nuclei. Morphologically dead cells showed complete colocal-
ization of YFP-Bax and 62M reactivity, and no colocalization
with mtHsp70 (Fig. 4 b). This suggests that of the Bax that
translocates to the OMM, only a small fraction of it is con-
formationally altered (i.e., is reactive with 62M). Movement
of all the mitochondrial Bax into clusters is associated with it
all undergoing this conformational change.
 
Figure 4 continued.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
C
e
l
l
 
B
i
o
l
o
g
y
 
 
 
Bax oligomers during anoikis |
 
 Valentijn et al. 605
 
Release of cytochrome 
 
c
 
 is a rapid and complete event, oc-
curring over a 5-min period once initiated (Goldstein et al.,
2000). These kinetics are similar in response to a range of
apoptotic stimuli. To determine the relationship between
cytochrome 
 
c
 
 release and redistribution of Bax within mi-
tochondria, YFP-Bax–expressing cells were detached for
various times and immunostained with an antibody to cy-
tochrome 
 
c
 
 and anti-Bax 62M. Only cells that had no
mitochondrial cytochrome 
 
c
 
 showed complete colocalization
of YFP-Bax with 62M immunoreactivity (Fig. 4 c). All cells
with released cytochrome 
 
c
 
 also had apoptotic nuclei.
The fact that we did not see any intermediate cells that
had Bax present in large clusters but still had mitochondrial
cytochrome 
 
c
 
 suggested that the formation of clusters and
MMP were rapid and coincident. Given the rapid kinetics of
cytochrome 
 
c
 
 release (Goldstein et al., 2000), it was impossi-
ble from these experiments to determine if Bax clusters
formed before or after MMP, caspase activation, and cell
death. To address this, we followed cluster formation in de-
tached cells in the presence or absence of zVAD-fmk. Cells
were cytospun and fixed after various times of anoikis, and
were immunostained for cytochrome 
 
c
 
 and TOM-20 (Fig. 5
a). As we have previously shown, inhibition of caspases did
not prevent Bax association with mitochondria after 15 min
(Gilmore et al., 2000). At later times, although nuclear con-
densation was inhibited by zVAD-fmk, cytochrome 
 
c
 
 release
and the formation of YFP-Bax clusters were unaffected, in-
dicating that they were independent of caspase activation.
Next, time-lapse images were taken of FSK-7 cells express-
ing CFP-Bax, YFP-caspase 3 sensor (which redistributes
from the cytosol to the nucleus on cleavage at a DEVD se-
quence), and HcRed-XT. Activation of caspase 3, loss of mi-
tochondrial membrane potential, and release of cytochrome
 
c
 
 occur rapidly and simultaneously (Goldstein et al., 2000;
Tyas et al., 2000). Furthermore, activation of Bax has been
shown to induce loss of mitochondrial membrane potential
 
Figure 4 continued.T
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Figure 5. Formation of Bax clusters 
occurs concomitant with (but does not 
require) caspase activation. (a) Cells 
expressing YFP-Bax were maintained 
in suspension for 15 min or 5 h, with or 
without 100  M zVAD-fmk. Cells were 
cytospun and immunostained for cyto-
chrome c and TOM-20. Nuclei were 
stained with Hoechst. Although zVAD-
fmk prevented nuclear condensation, it 
did not inhibit cytochrome c release or 
formation of YFP-Bax clusters. (b) Cells 
expressing CFP-Bax (Video 1), HcRed-XT 
(Video 2), and YFP-caspase 3 sensor 
(Video 3) were treated with 10  M 
staurosporine. Images were taken every 
3 min. t   0 represents the first image in 
the sequence presented, not the point 
at which staurosporine was added. 
Appearance of CFP-Bax clusters com-
mences at t   3, the same point at which 
YFP is first localized to the nucleus. 
See Videos 1–3 for complete image 
sequence. Merged image of CFP-Bax 
and HcRed-XT indicates Bax is redistrib-
uting into perimitochondrial clusters. 
Examples are indicated by arrows. (c) Cells 
expressing CFP-Bax (Video 4) were loaded 
with Rhodamine 123 (R123, Video 5) 
before adding staurosporine. Images 
were taken as in b. Loss of R123 local-
ization to mitochondria is first apparent 
at t   9, and CFP-Bax clusters form be-
tween t   3 and t   6. See Videos 4 and 
5 for complete image sequence. (d) Cells 
expressing CFP-Bax were stained with 
Hoechst, and treated with staurosporine. 
Images were taken every 5 min. t   0 
represents the first image presented. 
Bax clusters are apparent at t   20, and 
nuclear condensation commences at 
around t   35 to t   40.T
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directly (Gross et al., 1998). As we could not follow live im-
aging of detached cells over the time periods required for
apoptosis to occur, we used staurosporine as an apoptotic
stimulus. The kinetics of initial Bax translocation after stau-
rosporine treatment appear different to that during anoikis
(Capano and Crompton, 2002). Consequently, we concen-
trated on the appearance of Bax clusters and their relation-
ship to caspase activation, loss of mitochondrial membrane
potential, and nuclear condensation. Clusters of CFP-Bax
appeared simultaneously with the activation of caspase 3, as
judged by YFP redistribution to the nucleus (Fig. 5 b; Vid-
eos 1–3, available at http://www.jcb.org/cgi/content/full/
jcb.200302154/DC1). Bax redistribution into clusters oc-
curred over 6 min. Colocalization with HcR-XT clearly
showed that CFP-Bax was forming perimitochondrial clus-
ters at this time (Fig. 5 b, examples indicated by arrows).
The kinetics of cluster formation were unaffected by zVAD-
fmk (unpublished data). We examined loss of mitochondrial
membrane potential using Rhodamine 123 (Fig. 5 c; Videos
4 and 5). Bax clusters clearly form before loss of membrane
integrity. However, a reduction in localized Rh123 began
within 3–6 min of CFP-Bax clusters becoming apparent.
Complete loss of membrane potential occurred over a longer
period than caspase 3 activation. Only partial membrane
permeabilization may be sufficient to induce activation of
the caspase cascade. Formation of CFP-Bax clusters was also
seen consistently before any signs of nuclear condensation
(Fig. 5 d).
Together, these results demonstrate that during anoikis,
cytosolic Bax translocates to mitochondria within 15 min
and remains evenly distributed over the OMM until MMP.
Redistribution of Bax into perimitochondrial clusters is fol-
lowed after several minutes by the formation of apoptotic
nuclei. The rapidity of this process agrees with our data ob-
tained with detached, fixed cells, where we did not observe
any cells in an intermediate state with Bax clusters, but with
cells still showing mitochondrial cytochrome 
 
c
 
. Thus, the
formation of clusters occurs concomitant with, but indepen-
dent of, caspase activation, suggesting that they form at the
same time as MMP.
 
Epithelial cells undergoing anoikis commit to 
the apoptotic pathway before formation of 
large Bax clusters
 
It is unclear at what point a cell has become irreversibly
committed to apoptosis, and whether this relates to the
changes in Bax localization and complex formation. Previ-
ously, we have shown that if cells are replated after de-
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tachment for 
 
 
 
1 h, endogenous Bax is lost from the mito-
chondria and redistributes to the cytosol (Gilmore et al.,
2000). Now, we asked how long a cell needs to be kept in
suspension before irreversibly committing to apoptosis,
and whether this is related to the formation of Bax com-
plexes. FSK-7 cells expressing YFP-Bax were used to assess
complex formation and apoptosis commitment. Cells
were detached from ECM for varying times. Cells were
then cytospun onto slides, and Bax localization and apop-
tosis at that time were quantified. Virtually all cells
showed mitochondrial YFP-Bax after 15 min detachment
from ECM (Fig. 3 a). This did not change over increasing
times in suspension. YFP-Bax cells undergo apoptosis
only after several hours detachment, even though translo-
cation to mitochondria was rapid. In cells maintained on
poly-HEMA, an increase in apoptosis was not apparent
until after 3 h in suspension, and occurred in the majority
of cells by 5 h (Fig. 6 b).
To determine when cells could no longer be rescued from
apoptosis, they were replated onto ECM after being kept in
suspension for various times. When cells were maintained
in suspension and then allowed to reattach, the majority
(
 
 
 
90%) attached within 30 min. If cells were replated after
being in suspension for 15 min, the majority survived over the
following 18 h (Fig. 6 c). However, if maintained in suspen-
sion for 1 or 2 h before replating, 
 
 
 
50% of YFP-Bax–express-
ing cells were apoptotic after 18 h. This occurred despite the
level of apoptosis at the time of replating being identical to
that at 15 min, when cells could be rescued. These data sug-
gest that the point at which epithelial cells have committed to
apoptosis occurs before MMP and release of cytochrome 
 
c
 
.
 
Discussion
 
Translocation of Bax is associated with both a conforma-
tional change and oligomerization into high mol wt com-
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plexes (Goping et al., 1998; Desagher et al., 1999; Gilmore
et al., 2000; Antonsson et al., 2001). These events have been
linked with its activation from a latent, cytosolic form, to a
proapoptotic one on the OMM (Gross et al., 1998; Antons-
son et al., 2000; Korsmeyer et al., 2000; Kuwana et al.,
2002). However, the relationship between Bax transloca-
tion, its conformational change, the formation of large mito-
chondrial clusters, and their requirement for downstream
apoptotic events is not clear.
In adhesion-dependent epithelial cells, Bax translocation
occurs rapidly after detachment from ECM (Gilmore et al.,
2000; Wang et al., 2003). Despite this, the release of cyto-
chrome 
 
c
 
 and morphological apoptosis occur in a stochastic
manner over several hours. This delay between apoptotic
signal and death prompted us to investigate the kinetics of
Bax translocation and oligomer assembly, and how these re-
late to mitochondrial permeabilization. We have shown that
Bax translocates to mitochondria as an inactive monomer.
Oligomerization occurs after association with the OMM.
Although activated Bax is detectable on mitochondria im-
mediately after detachment, this is a fraction of the total
protein and is restricted to small foci. Only when mitochon-
dria permeabilize is the majority of Bax found in perimito-
chondrial clusters. Time-lapse experiments show that forma-
tion of these clusters is concomitant with caspase activation,
and before nuclear condensation. Both MMP and cluster
formation occur in the presence of caspase inhibitors.
 
Translocation of Bax to mitochondria precedes 
both its conformational change and formation of 
large complexes
 
Our data clearly indicate that Bax translocation and confor-
mational change into its “active” form are distinct molecular
events, although they are often described as being one and
the same. We only detected active Bax on the membrane
fraction of detached cells, and the small proportion of Bax
present in the membrane fraction of adherent cells was not
immunoprecipitated with conformation-specific antibodies.
Furthermore, cytosolic Bax could not be immunoprecipi-
tated from detached cells, at either early (before MMP) or
late stages of anoikis. These data indicate that after a physio-
logical death stimulus, translocation must occur before, and
not as a consequence of, the conformational change. This is
supported by data from HeLa cells, where Bax can be consti-
tutively associated with mitochondria, but not in the active
conformation (Desagher et al., 1999). The COOH-terminal
tail appears to drive mitochondrial targeting, and mutations
within it can uncouple translocation from apoptosis (Wolter
et al., 1997; Nechushtan et al., 1999). The three-dimen-
sional structure of Bax shows remarkable similarity to anti-
apoptotic Bcl-X
 
L
 
 (Muchmore et al., 1996; Suzuki et al.,
2000). Unlike Bcl-X
 
L
 
, the structure of Bax was solved with
the COOH-terminal mitochondrial-targeting sequence (he-
lix 9) present, lying within a hydrophobic groove along the
surface of the molecule. The similarity between the struc-
tures of Bax and Bcl-X
 
L
 
 suggests that occupation of this
groove is not required for helices 1–8 to fold correctly.
Therefore, one can envision that altering the orientation of
helix 9 may regulate translocation without affecting the con-
Figure 6. Cell commitment to apoptosis follows Bax translocation, 
but is before formation of perimitochondrial clusters. (a) Cells 
transiently expressing YFP-Bax were detached for various times 
before cytospinning onto slides. Cells were immunostained for 
TOM-20, and the percentage of transfected cells showing mito-
chondrial YFP-Bax was determined. Error bars are SEM from three 
experiments. (b) Cells were stained with Hoechst (as in a). Apoptosis 
in YFP-Bax–positive cells was quantified. Error bars are SEM from 
three experiments. (c) YFP-Bax–expressing cells were replated 
onto ECM at the same time points as cells were cytospun in b. 
Cells were then cultured for a total of 18 h from the start of the 
experiment. All cells were collected, and were stained with Hoechst. 
Apoptosis was quantified in YFP-positive cells. Error bars are SEM 
from three experiments.T
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formation of the NH
 
2
 
 terminus (Suzuki et al., 2000). Our
data, showing that only a fraction of the YFP-Bax on mito-
chondria of detached cells colocalizes with 62M reactivity,
supports this hypothesis.
Large oligomers of Bax are clearly associated with apopto-
sis, though their function and composition is far from clear
(Antonsson et al., 2001). Conversely, cytosolic Bax is a
monomer. Oligomerization and dimerization have been sug-
gested as mechanisms that regulate Bax association with and
insertion into the OMM (Antonsson et al., 2000; Kors-
meyer et al., 2000; Suzuki et al., 2000; Kuwana et al., 2002).
Forcing cytosolic Bax to dimerize induced translocation in
FL5.12 cells (Gross et al., 1998). However, these enforced
dimers did not result in release of cytochrome 
 
c
 
, suggesting
that they were not functioning in the same way as endoge-
nous Bax. The BH3-only protein BID can induce the for-
mation of Bax dimers and trimers, leading to insertion into
isolated mitochondria (Eskes et al., 2000). We clearly saw
that in the initial stages of anoikis, Bax had translocated pri-
marily as a monomer. Our cross-linking data also indicated
that dimers were not required for translocation, though we
could see dimers induced by addition of Triton X-100. In-
terestingly, dimers, trimers, and tetramers were not seen in
our cross-linking experiments with detached cells at any
time point, suggesting that if they do occur and play a role
in MMP, then they must exist very transiently in only those
cells in which it is occurring. Larger complexes appear over
time in suspension, being more apparent at 1 h and particu-
larly at 4 h. However, the analysis of Bax complexes by gel
filtration does come with caveats, as they represent an aver-
age of a cell population in which cell death occurs in a sto-
chastic manner. This is seen with other death-inducing stim-
uli, where MMP appears to occur randomly within a
population of cells that will all ultimately undergo apoptosis
(Goldstein et al., 2000). Therefore, from these experiments,
it is impossible to determine whether complexes are forming
in all cells over time, or if they occur only in those cells that
have undergone MMP and have become apoptotic. Our sin-
gle-cell analysis of cells expressing fluorescently tagged Bax
suggests that large clusters only form in cells that are under-
going MMP, and that their formation is rapidly followed by
downstream apoptotic events.
 
Do large perimitochondrial clusters represent the 
functional Bax complex?
 
Bax has been shown to form a variety of different-sized com-
plexes, and this oligomerization has been shown to be re-
quired for Bax to permeabilize membranes in cell-free sys-
tems (Antonsson et al., 2000). Formation of dimers and
tetramers occur in a concentration-dependent manner in
vitro, the latter of which can form cytochrome 
 
c
 
–conducting
channels in isolated mitochondria and lipid vesicles (Saito et
al., 2000; Pavlov et al., 2001). Yet larger Bax complexes
(
 
 
 
200 kD) are seen by gel filtration in CHAPS-extracted
mitochondria here and elsewhere (Antonsson et al., 2001).
Analysis of YFP-Bax clusters has suggested much larger com-
plexes, containing thousands of Bax molecules (Nechushtan
et al., 2001). However, recent data suggests that very large
Bax complexes do not have permeabilizing activity, whereas
smaller complexes (
 
 
 
100 kD) can release proteins up to
megadalton sizes (Kuwana et al., 2002). We found that
much of the Bax present in cells after several hours of anoikis
was resistant to CHAPS extraction, as were the perimito-
chondrial clusters of YFP-Bax in cells with apoptotic nuclear
morphology. Therefore, very large Bax clusters must be dif-
ferent from the 200-kD complexes seen by gel filtration of
CHAPS-extracted mitochondria, and may represent the
endpoint of mitochondrial permeabilization. Therefore, the
active complex that releases intermembrane proteins may be
extremely transient, and may result in large, insoluble aggre-
gates of Bax after permeabilization. Time-lapse imaging of
single cells undergoing apoptosis in response to staurospo-
rine indicates that cluster formation is rapid, occurring over
a few minutes exactly when caspase activity can be first de-
tected at a single-cell level. MMP is also a sudden, complete,
and dramatic event, releasing cytochrome 
 
c
 
 within 5 min of
commencement (Goldstein et al., 2000). This is consistent
with our inability to identify intermediate complexes by
cross-linking. Together with our data, it appears that forma-
tion of Bax clusters occurs rapidly at the same time as MMP.
Do these large clusters have a role in apoptosis? It has been
hypothesized that Bax may act as a protein translocase,
rather than by forming a permanent membrane channel (La-
zebnik, 2001). Some evidence for this exists. The transport
of megadalton dextrans across the OMM has been shown to
occur without the formation of permanent pores or mem-
brane disruption (Kuwana et al., 2002). If this requires Bax
to unfold and form transient pores, then it may subse-
quently form large aggregates adjacent to mitochondria. In-
deed, unfolding purified Bax with detergents induces it to
form large aggregates (Suzuki et al., 2000). Mitochondria
can regulate protein unfolding, and this may have a role in
apoptosis regulation (Matouschek et al., 2000; Thress et al.,
2001). Therefore, large perimitochondrial clusters might
represent a by-product of a process involving Bax unfolding
during MMP. Clusters may have other roles, and several
proteins have also been identified in them, including Drp-1
and Mfn-1 (Karbowski et al., 2002). These regulate mito-
chondrial fission during apoptosis, although inhibition of
Drp-1 did not prevent Bax itself from forming large com-
plexes (Frank et al., 2001). Interactions with these or other
mitochondrial proteins may be required for mitochondrial
fragmentation, but it is unclear if they are required for Bax
apoptotic activity (Roucou et al., 2002).
 
Epithelial cells commit to apoptosis before the 
appearance of Bax oligomers
 
It has been presumed that the point at which a cell has irre-
versibly committed to apoptosis equates with release of cyto-
chrome 
 
c
 
, SMAC/Diablo, and other proapoptotic factors
(Zamzami and Kroemer, 2003). Unlike many model sys-
tems used to study the kinetics of apoptosis, detached cells
can be rescued if they are allowed to reattach to ECM
(Gilmore et al., 2000). We have used this system to de-
termine the temporal relationship between the molecular
events associated with Bax activation and commitment to
apoptosis. Our data suggest that, although the formation of
large Bax clusters is associated with release of cytochrome 
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and apoptosis, cells actually pass the point of commitment
before these events. The majority of epithelial cells kept in
suspension for 
 
 
 
1 h could not be rescued by replating them
onto ECM, eventually showing apoptotic morphology.
However, cells replated after only 15 min of anoikis were
rescued. At the time of replating, YFP-Bax was present on
the mitochondria of all cells, but had not yet formed large
clusters or resulted in cytochrome 
 
c
 
 release. The conclusion
must be that neither Bax translocation nor complex forma-
tion mark the point of commitment. This raises interesting
questions regarding events occurring on the mitochondrial
surface after an apoptotic stimulus but before MMP. The
answers to these questions may explain the stochastic nature
of this process in response to diverse cellular insults.
 
Materials and methods
 
Antibodies and reagents
 
The polyclonal anti-Bax antibody 62M has been described previously (Pul-
lan et al., 1996; Gilmore et al., 2000). Polyclonal anti-Bax recognizing the
whole molecule was purchased from Santa Cruz Biotechnology, Inc.
Monoclonal anti-Bax 5B7 was purchased from Sigma-Aldrich. Anti-mito-
chondrial Hsp-70 (JG1), was purchased from Affinity BioReagents, Inc. The
TOM-20 antibody was a gift from David Breckenridge and Gordon Shore
(McGill University, Montreal, Quebec, Canada). Monoclonal anti-cyto-
chrome 
 
c
 
 was purchased from BD Biosciences. Triton X-100 and CHAPS
were purchased from Sigma-Aldrich. BS3 was purchased from Pierce.
Rhodamine 123 was obtained from Sigma-Aldrich.
 
Expression constructs
 
The Bax cDNA was amplified from mouse embryo cDNA with Pfu poly-
merase (Promega) using oligonucleotide primers to the 5
 
 
 
 and 3  ends of
the coding sequence, cloned into pCRScript (Stratagene), and confirmed
by sequencing. To generate YFP-Bax, PCR primers were used that incor-
porated restriction endonuclease sites and the Bax start and stop codons.
The product was ligated into either pEYFP-C1 or pECFP-C1 (CLONTECH
Laboratories, Inc.). The BH3 domain construct was generated using PCR
primers based on the three-dimensional structure of Bax, and restriction
sites were incorporated into each primer. This was cloned into pEYFP-C1.
The inactive BH3 mutant was constructed using PCR primers to incorpo-
rate a double point mutation (L64 to E and G68 to E). pHcRed1-XT and
pEYFP-XT were made by PCR from a Bcl-XL cDNA (a gift from Richard
Youle, National Institutes of Health, Bethesda, MD), using primers that en-
compassed the coding sequence for the last 25 amino acids including the
stop codon. pEYFP-caspase 3 sensor was purchased from CLONTECH Lab-
oratories, Inc. All constructs were confirmed by DNA sequencing and im-
munoblotting.
Cell culture and transfection
FSK-7 cells (Kittrell et al., 1992) were grown in DME/Ham’s F12 (2% FCS,
5 ng/ml EGF, and 880 nM insulin). Transfection of FSK-7 cells with Lipo-
fectAMINE™ plus (Life Technologies) has been described previously
(Gilmore et al., 2000). In brief, cells were plated at 10
5 cells/cm
2 on glass
coverslips 18 h before transfecting with 0.5  g DNA in 12-well culture
plates. For detachment assays, cells were trypsinized and replated on 35-
mm dishes coated with poly-HEMA (Sigma-Aldrich). Cells on poly-HEMA
were collected by centrifugation (5,000 g, 30 s). For immunostaining, cells
were resuspended in culture medium and centrifuged onto polylysine
slides (Merck) using a centrifuge (Cytospin; Shandon).
Cell fractionation, chromatography, cross-linking, 
and immunoprecipitation
Manipulations were performed on ice unless otherwise stated. Cells were
resuspended in hypotonic buffer (10 mM Hepes, pH 7.6, 10 mM NaCl, 1.5
mM/MgCl2, 4 mM NaF, 100  M sodium orthovanadate, and protease in-
hibitors) and were lysed with 20 strokes in a Dounce homogenizer
(Wheaton), followed by addition of NaCl to 150 mM. Cytosol and mem-
brane fractions were separated by centrifugation (100,000 g for 30 min).
For size-exclusion chromatography, CHAPS was added to the cytosol frac-
tion to 4 mM. To extract the membrane fraction, the 100,000-g pellet was
resuspended in 10 mM Hepes/Cl, pH 7.6, 150 mM NaCl, 4 mM CHAPS, 4
mM NaF, 100  M sodium orthovanadate, and protease inhibitors, and was
sonicated. The solubilized membrane fraction was centrifuged at 100,000 g.
The insoluble material left at this stage was solubilized by boiling in
SDS-PAGE sample buffer. Lysates were concentrated in Centricon 10 con-
centrators (Amicon), and 5 mg protein in 0.5 ml was loaded onto a
Sephacryl S100-HR column (1.5   25 cm, Amersham Biosciences; equili-
brated in 10 mM Hepes/Cl, pH 7.6, 150 mM NaCl, and 4 mM CHAPS).
The column was resolved at 4 C, flow rate 0.1 ml/minute. Calibration was
with mol wt standards from Sigma-Aldrich (12.4 kD, cytochrome c; 29 kD,
carbonic anhydrase; 66 kD, BSA; 200 kD,  -amylase; void volume, blue
dextran). Column fractions were concentrated with TCA, separated by re-
ducing SDS-PAGE, transferred to nitrocellulose (Bio-Rad Laboratories), and
immunoblotted. For cross-linking experiments, lysates were incubated
with 5 mM BS3 for 30 min at RT. Where indicated, Triton X-100 or CHAPS
was added 30 min before BS3. Reactions were stopped with SDS-PAGE
sample buffer. Reactions were separated by SDS-PAGE. For immunopre-
cipitation of active Bax, soluble and membrane fractions isolated in 4 mM
CHAPS buffer were clarified by centrifugation. 1 mg protein was precipi-
tated with 1  g/ml anti-Bax antibody 62M on protein A–Sepharose (Roche)
at 4 C for 2 h, and was washed three times in CHAPS buffer. Proteins were
recovered by boiling the beads in SDS-PAGE sample buffer before immu-
noblotting with anti-Bax 5B7. Immunoblots were visualized with SuperSig-
nal
® chemiluminescence (Pierce Chemical Co.).
Immunofluorescence microscopy and live-cell imaging
Cells fixed in 3.7% PFA/PBS were permeabilized in PBS/0.5% Triton
X-100. Primary antibodies were diluted in PBS/0.1% Triton X-100/0.1%
horse serum (37 C for 1 h). After washing in PBS, secondary goat anti–
mouse or goat anti–rabbit Cy5 or Cy3 conjugates were incubated in above
buffer (37 C for 30 min). Cells were counterstained with 1  g/ml Hoescht
33258. Coverslips were mounted in ProLong
® (Molecular Probes, Inc.).
Images were collected on an inverted microscope (model IX70; Olympus)
using a 100  Plan-Apo 1.4 NA objective, equipped with a DeltaVision
imaging system. Images were processed by constrained iterative deconvo-
lution on softWoRx™ v3.0 software (Applied Precision). For live imaging,
cells expressing fluorescently tagged proteins were incubated with 1  g/ml
Hoescht 33258 and/or 5  M Rhodamine 123 for 30 min before washing in
growth medium, and 10  M staurosporine was added. Images were cap-
tured using a Leica AS-MDW workstation (37 C, 5% CO2) with an HCX
Plan-Apo 63 /1.3 NA glycerol objective.
Online supplemental material
Videos 1–3 show FSK-7 cells treated with staurosporine (images taken ev-
ery 3 min), and are the complete sequence from which Fig. 5 b was com-
piled. Videos 4 and 5 show FSK-7 cells loaded with Rhodamine 123 and
treated with staurosporine, and are the complete sequence from which Fig.
5 c was compiled. Online supplemental material available at http://
www.jcb.org/cgi/content/full/jcb.200302154/DC1.
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